Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
about
Cystatin C modulates cerebral beta-amyloidosisAmyloid properties of the leader peptide of variant B cystatin C: implications for Alzheimer and macular degenerationCystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse modelsThe role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal modelsCystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines.Biochemistry and clinical role of human cystatin C.Protective mechanisms by cystatin C in neurodegenerative diseases.Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresisA missense variant in CST3 exerts a recessive effect on susceptibility to age-related macular degeneration resembling its association with Alzheimer's disease.Evidence of Alternative Cystatin C Signal Sequence Cleavage Which Is Influenced by the A25T Polymorphism.Cystatin C in Alzheimer's disease.Complexes of amyloid-beta and cystatin C in the human central nervous system.Mechanisms of amyloid fibril formation--focus on domain-swapping.Directional protein secretion by the retinal pigment epithelium: roles in retinal health and the development of age-related macular degeneration.Cystatin C in aging and in Alzheimer's disease.Putative alternative functions of human stefin B (cystatin B): binding to amyloid-beta, membranes, and copper.Contribution of cystatin C gene polymorphisms to cerebral white matter lesions.Cystatin C protects neuronal cells from amyloid-beta-induced toxicity.Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.Unexpected intracellular localization of the AMD-associated cystatin C variant.Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?Meta-analysis of the cystatin C(CST3) gene G73A polymorphism and susceptibility to Alzheimer's disease.The CST3 B haplotype is associated with frontotemporal lobar degeneration.Cystatin C is differentially involved in multiple system atrophy phenotypes.Co-chaperoning by amyloid-forming proteins: cystatins vs. crystallins.Cystatin C: a potential target for Alzheimer's treatment.
P2860
Q24300978-F46ABA69-28B2-4BD3-9254-B5BCD5B8BE9FQ28118595-53508031-A9E6-49A0-BC0B-B0F37DF9913DQ28258089-AA5007B8-53D2-4A29-BD68-E44725527425Q28307028-4CE9F7BD-16E6-4A15-8997-EC2EFBEA152CQ30490690-B1A8A946-C2BC-4BDA-8AE6-4B0F4F0D9582Q33547453-6A4B4464-5896-4AA4-A8BD-241FEF7EFAC8Q34377103-A4F73ED4-7F02-4BEF-8B8D-2A08CA2FE14CQ34572391-48249C16-2CF2-42CA-B578-0E9F6AEF6406Q34576418-65355871-B469-498B-AB4D-20246910307CQ35698081-FC5F38DC-08CB-4CD2-BDFC-E6320525428EQ35914308-4D2EDB78-4D89-427B-8B6F-987E90013D18Q36078684-5968E504-3B53-4D86-B034-1FA29D519477Q37474236-1955AB47-C00B-4371-9FE1-E051F88E75BBQ37871074-90928A45-9A8A-4EAD-984E-E2F8CD415483Q38105656-863DEE85-C137-42CC-B9D5-949DD064421DQ38873507-EE37D0DA-63AD-4F21-91FC-01481A5DCE92Q39438003-44AF676A-39EE-4FE4-ADF1-B6A8411B29D1Q39447438-C4AB9298-96E7-4A73-A5FC-309AC9EBE28CQ39739201-DEBDBFF7-C690-4F86-BA6D-C7CBF43CF2E8Q41597801-B8E575F5-94EB-46F7-9267-CCB52B84BA92Q45103067-68377F6F-FCE3-40B3-B7D4-F24AD47D18B9Q47271759-D1908DB1-896F-49B3-8135-7C97B22DEEA2Q47997840-FEDA5C20-C4A9-41BE-97BC-7E9E2A3F0755Q48487351-392AAF49-6D59-4B81-862C-C422D0825CB8Q50477602-4F4361D6-3BB0-4C70-BF0D-C405ABC5A4C2Q51016822-AB1A9CA0-931D-409F-9CA4-6B756E6A2B3BQ53392955-5A008604-83F4-45C9-B4AD-0892D318ABC2
P2860
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@en
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@nl
type
label
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@en
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@nl
prefLabel
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@en
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@nl
P2093
P1476
Alzheimer disease-associated cystatin C variant undergoes impaired secretion.
@en
P2093
Aldo Villa
Antonella Alberici
Enrica Feudatari
Federica Mazzoli
Francesca Nicosia
Giuliano Binetti
Laura Barbiero
Laura Broglio
Roger M Nitsch
Simona Signorini
P356
10.1016/S0969-9961(03)00012-3
P577
2003-06-01T00:00:00Z